Portfolio Update

Summary by AI BETAClose X

BlackRock American Income Trust PLC reported its unaudited performance as of August 31, 2025. The net asset value increased by 1.5% for the month, outperforming the Russell 1000 Value Index by 0.4%. The net asset value per share was 215.46p cum income and 215.34p capital only, while the share price stood at 207.00p, representing a discount of 3.9% to cum income NAV. The company's net yield was 5.0%, and total assets, including current year revenue, amounted to £121.5 million with net gearing at 1.3%. Ongoing charges were 1.06%, and there were 56,412,138 ordinary shares in issue. The top sector allocation was Financials at 22.4% of total assets.

Disclaimer*

 

BLACKROCK AMERICAN INCOME TRUST PLC (LEI:549300WWOCXSC241W468)
All information is at 31 August 2025 and unaudited.
Performance at month end with net income reinvested
 

 

 

 

 One

 Month

Three

Months

Six

Months

 One

 Year

 Three

 Years

Five Years

Net asset value

1.5

7.4

-0.2

4.1

14.3

63.2

Share price

3.1

7.7

3.8

10.3

17.0

68.9

Russell 1000 Value Index

1.1

7.1

-2.4

6.3

23.9

82.4

Russell 1000 Value Index (Net 15% WHT Total Return)*

 

1.0

7.1

-2.6

6.0

22.6

79.4

 

*The Company’s performance reference index (the Russell 1000 Value Index) may be calculated on either a gross or a net return basis. Net return (NR) indices calculate the reinvestment of dividends net of withholding taxes using the tax rates applicable to non-resident institutional investors and hence give a lower total return than indices where calculations are done on a gross basis. As the Company is subject to the same withholding tax rates for the countries in which it invests, the NR basis is felt to be the most accurate, appropriate, consistent and fair comparison of performance returns for the Company.

 

At month end

Net asset value - capital only:

215.34p

Net asset value - cum income:

215.46p

Share price:

207.00p

Discount to cum income NAV:

3.9%

Net yield1:

5.0%

Total assets including current year revenue:

£121.5m

Net gearing:

1.3%

Ordinary shares in issue2:

56,412,138

Ongoing charges3:

1.06%

 

1 Based on one quarterly dividend of 2.00p per share declared on 13 November 2024 for the year ended 31 October 2024, one quarterly dividend of 2.00p per share declared on 01 April 2025, one quarterly dividend of 3.03p per share declared on 15 May 2025 and one quarterly dividend of 3.23p per share declared on 07 August 2025 for the year ending 31 October 2025 and based on the share price as at close of business on 31 August 2025.

² Excluding 38,949,167 ordinary shares held in treasury.

³ The Company’s ongoing charges calculated as a percentage of average daily net assets and using the management fee and all other operating expenses excluding finance costs, direct transaction costs, custody transaction charges, VAT recovered, taxation and certain non-recurring items for the year ended 31 October 2024.

 

=

 

 

 

 

 

 

 

 

 

 

 

Sector Analysis

Total Assets (%)

Financials

22.4

Industrials

13.5

Health Care

13.1

Information Technology

12.6

Consumer Discretionary

9.3

Communication Services

7.2

Consumer Staples

6.6

Energy

5.0

Utilities

4.2

Real Estate

3.5

Materials

3.3

Net Current Liabilities

-0.7

 

-----

 

100.0

 

=====

 

 

Country Analysis

Total Assets (%)

United States

100.7

Net Current Liabilities

-0.7

 

-----

 

100.0

 

=====

 

 

 #

 

Top 10 Holdings

Country

% Total Assets

Alphabet

United States

3.2

JPMorgan Chase

United States

3.1

Berkshire Hathaway

United States

2.9

Amazon

United States

2.6

Walmart

United States

2.4

Bank Of America

United States

2.4

Morgan Stanley

United States

1.8

Charles Schwab

United States

1.7

Pfizer

United States

1.7

Procter & Gamble

United States

1.5

 

 

 

 

Travis Cooke and Muzo Kayacan, representing the Investment Manager, noted:

 

For the month ended 31 August 2025, the Company’s NAV rose by 1.5% in Sterling terms, outperforming the Russell 1000 Value Index by 0.4% (Net Total Return).

 

August was a strong month for equities as macro sentiment improved. Markets rallied broadly on expectations of Federal Reserve rate cuts and easing concerns over trade policy, supporting growth-sensitive sectors. We had strong positioning in Information Technology and Consumer Discretionary, where we were modestly overweight, and in Industrials, where we maintained a small underweight exposure. Together, these three sectors accounted for over a third of the portfolios risk budget and were key contributors to outperformance.

 

On the signal side, the largest contributor was our machine-learned model trained on large-cap stocks doing particularly well, which added over 15bps of alpha. Importantly, outperformance was broad and diversified.

 

From a stock perspective, several overweight exposures were especially additive. Berkshire Hathaway’s investment in UnitedHealth triggered an 11% one-day jump in the stock, which we were positioned to capture1. Apple was another strong contributor, where our tactical asset allocation and volume-price momentum indicators identified the sentiment reversal following its $100bn U.S. investment pledge that helped ease tariff concerns2. By contrast, Cardinal Health, which had been a notable driver in June supported by medical invoice data signals, detracted this month as shares fell sharply on news of its $1.9bn acquisition of Solaris Health3.

 

1 UnitedHealth surges after Warren Buffett bets on recovery | Reuters

2 Apple increases U.S. commitment to $600 billion, announces ambitious program - Apple

3 Cardinal Health to buy Solaris Health for $1.9 billion, posts weak results | Reuters

 

Source: BlackRock.

 

7 October 2025

 

Latest information is available by typing blackrock.com/uk/brai on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal).  Neither the contents of the Manager’s website nor the contents of any website accessible from hyperlinks on the Manager’s website (or any other website) is incorporated into, or forms part of, this announcement.

 




Release

UK 100

Latest directors dealings